InvestorsHub Logo

Monroe1

10/26/22 12:31 PM

#215099 RE: SAF666 #215088

Oh I meant triple...three fingers worth. That is what is in store for the near future.

https://seekingalpha.com/article/4546936-cytodyn-repositioning-and-refocusing-with-new-leadership

[In dispute are concerns that the data collected by Amarex was improperly coded and not in accordance to current industry standard format. According to CEO Arman at 12:30 minutes in this webcast,

"It's important to note that substantially, all of the data requested by the FDA to lift the clinical hold are items that Amarex was contracted by CYDY to prepare but, failed to do so."

As a result, an external audit by a high quality independent research company has been retained by CYDY in order to audit the quality of the data collected and monitoring performed by Amarex.]

Oh My God... they are going to pay out the nose. Both nostrils will be pouring out tons of development cash. $CYDY$ Come now, give those cheapies!!